ebomi
Colour theme
Sign in
Insider · CIK 0001273979

Barnhill Gregory Hurd

CIK 0001273979 Name as filed on the most recent filing

Filed as Barnhill Gregory Hurd (25)

35 transaction lines · from 25 filings · filed 2008-04-07 to 2011-07-01 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

35 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

Transactions filed by this insider
Direction Date Code Company Value USD Filing
2011-06-29 P, Open-market purchase Pure Bioscience, Inc.PURE 38,765, acquired Open Form 4 filing 0001079973-11-000551
2011-06-21 P, Open-market purchase Pure Bioscience, Inc.PURE 22,345, acquired Open Form 4 filing 0001079973-11-000532
2011-06-06 P, Open-market purchase Osiris Therapeutics, Inc.OSIR 176,695, acquired Open Form 4 filing 0001179110-11-009286
2011-06-03 P, Open-market purchase Osiris Therapeutics, Inc.OSIR 179,965, acquired Open Form 4 filing 0001179110-11-009286
2010-07-07 P, Open-market purchase Pure BiosciencePURE 9,200, acquired Open Form 4 filing 0001079973-10-000753
2010-04-14 P, Open-market purchase Pure BiosciencePURE 13,600, acquired Open Form 4 filing 0001079973-10-000479
2010-04-06 P, Open-market purchase Pure BiosciencePURE 20,156, acquired Open Form 4 filing 0001079973-10-000437
2010-03-15 P, Open-market purchase Pure BiosciencePURE 18,000, acquired Open Form 4 filing 0001079973-10-000320
2010-01-27 S, Open-market sale Pure BiosciencePURE 38,521, disposed Open Form 4 filing 0001079973-10-000074
2010-01-26 S, Open-market sale Pure BiosciencePURE 54,544, disposed Open Form 4 filing 0001079973-10-000074
2010-01-21 S, Open-market sale Pure BiosciencePURE 41,873, disposed Open Form 4 filing 0001079973-10-000045
2010-01-20 S, Open-market sale Pure BiosciencePURE 42,412, disposed Open Form 4 filing 0001079973-10-000045
2010-01-19 S, Open-market sale Pure BiosciencePURE 5,250, disposed Open Form 4 filing 0001079973-10-000045
2010-01-15 S, Open-market sale Pure BiosciencePURE 1,082, disposed Open Form 4 filing 0001079973-10-000028
2010-01-14 S, Open-market sale Pure BiosciencePURE 1,743, disposed Open Form 4 filing 0001079973-10-000028
2010-01-13 S, Open-market sale Pure BiosciencePURE 18,828, disposed Open Form 4 filing 0001079973-10-000028
2009-12-24 S, Open-market sale Pure BiosciencePURE 1,390, disposed Open Form 4 filing 0001079973-09-001246
2009-12-23 S, Open-market sale Pure BiosciencePURE 2,145, disposed Open Form 4 filing 0001079973-09-001225
2009-12-22 S, Open-market sale Pure BiosciencePURE 31,384, disposed Open Form 4 filing 0001079973-09-001225
2009-12-21 S, Open-market sale Pure BiosciencePURE 51,134, disposed Open Form 4 filing 0001079973-09-001225
2009-07-21 P, Open-market purchase Pure BiosciencePURE 16,700, acquired Open Form 4 filing 0001079973-09-000716
2009-04-23 P, Open-market purchase Pure BiosciencePURE 8,450, acquired Open Form 4 filing 0001079973-09-000396
2009-04-07 P, Open-market purchase Pure BiosciencePURE 8,750, acquired Open Form 4 filing 0001079973-09-000353
2009-03-20 P, Open-market purchase Pure BiosciencePURE 8,750, acquired Open Form 4 filing 0001079973-09-000311
2009-03-18 P, Open-market purchase Pure BiosciencePURE 9,100, acquired Open Form 4 filing 0001079973-09-000295
2009-03-16 P, Open-market purchase Pure BiosciencePURE 9,677, acquired Open Form 4 filing 0001079973-09-000295
2008-12-29 P, Open-market purchase Pure BiosciencePURE 30,203, acquired Open Form 4 filing 0001079973-08-001181
2008-10-24 P, Open-market purchase Pure BiosciencePURE 8,910, acquired Open Form 4 filing 0001079973-08-000994
2008-10-23 P, Open-market purchase Pure BiosciencePURE 29,500, acquired Open Form 4 filing 0001079973-08-000983
2008-10-22 P, Open-market purchase Pure BiosciencePURE 29,500, acquired Open Form 4 filing 0001079973-08-000983
2008-10-17 P, Open-market purchase Pure BiosciencePURE 30,020, acquired Open Form 4 filing 0001079973-08-000970
2008-07-02 P, Open-market purchase Pure BiosciencePURE 38,042, acquired Open Form 4 filing 0001079973-08-000637
2008-06-26 P, Open-market purchase Pure BiosciencePURE 41,800, acquired Open Form 4 filing 0001079973-08-000628
2008-04-21 P, Open-market purchase Pure BiosciencePURE 47,000, acquired Open Form 4 filing 0001079973-08-000436
2008-04-07 P, Open-market purchase Pure BiosciencePURE 57,170, acquired Open Form 4 filing 0001079973-08-000392

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Search the catalog
Codes on this page
P, Open-market purchase
Open-market purchase
S, Open-market sale
Open-market sale
Relationships on this page
D, Director
Director

Every value is as reported on the Form 4, totalled to the dollar. Share counts, the price per share and the full list of reporting owners are on each filing's own page, which every row here opens.

What this insider's stored lines contain

Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.

  • Open-market purchase 23
  • Open-market sale 12
  • Option exercise 0
  • Grant or award 0
  • Tax withholding 0
  • Disposition to the issuer 0
  • In-the-money option exercise 0

How to cite this page

ebomi catalog. BARNHILL GREGORY HURD, insider transactions. Retrieved 2026-08-24 from https://ebomi.com/insider/0001273979

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.